Affinity purification of HIV-1 and HIV-2 proteases from recombinant E. coli strains using pepstatin-agarose. 1990

J Rittenhouse, and M C Turon, and R J Helfrich, and K S Albrecht, and D Weigl, and R L Simmer, and F Mordini, and J Erickson, and W E Kohlbrenner
Pharmaceutical Products Division, Abbott Laboratories, IL 60064-3500.

A procedure is described which employs pepstatin-agarose for the affinity purification of either HIV-1 or HIV-2 protease from two similar recombinant E. coli constructs that were developed for the expression of these enzymes. HIV-2 protease was routinely expressed at much higher levels than the HIV-1 enzyme and pepstatin-agarose was the only chromatography step required to isolate pure HIV-2 protease from crude bacterial lysates. A Mono S ionic exchange step following pepstatin-agarose chromatography was sufficient to bring the HIV-1 protease to homogeneity. Purification of either enzyme can be completed in several days yielding homogeneous preparations suitable for crystallization and other physical characterization.

UI MeSH Term Description Entries
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D010436 Pepstatins N-acylated oligopeptides isolated from culture filtrates of Actinomycetes, which act specifically to inhibit acid proteases such as pepsin and renin.
D010450 Endopeptidases A subclass of PEPTIDE HYDROLASES that catalyze the internal cleavage of PEPTIDES or PROTEINS. Endopeptidase,Peptide Peptidohydrolases
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002846 Chromatography, Affinity A chromatographic technique that utilizes the ability of biological molecules, often ANTIBODIES, to bind to certain ligands specifically and reversibly. It is used in protein biochemistry. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Bioaffinity,Immunochromatography,Affinity Chromatography,Bioaffinity Chromatography
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015498 HIV-2 An HIV species related to HIV-1 but carrying different antigenic components and with differing nucleic acid composition. It shares serologic reactivity and sequence homology with the simian Lentivirus SIMIAN IMMUNODEFICIENCY VIRUS and infects only T4-lymphocytes expressing the CD4 phenotypic marker. HTLV-IV,Human T-Lymphotropic Virus Type IV,Human immunodeficiency virus 2,LAV-2,HIV-II,Human Immunodeficiency Virus Type 2,Human T Lymphotropic Virus Type IV,Immunodeficiency Virus Type 2, Human,SBL-6669
D015684 Gene Products, pol Retroviral proteins coded by the pol gene. They are usually synthesized as a protein precursor (POLYPROTEINS) and later cleaved into final products that include reverse transcriptase, endonuclease/integrase, and viral protease. Sometimes they are synthesized as a gag-pol fusion protein (FUSION PROTEINS, GAG-POL). Pol is short for polymerase, the enzyme class of reverse transcriptase. pol Gene Products,pol Polyproteins,pol Protein,Gene Product, pol,pol Polyprotein,Polyprotein, pol,Polyproteins, pol,Protein, pol,pol Gene Product
D016333 HIV Protease Enzyme of the human immunodeficiency virus that is required for post-translational cleavage of gag and gag-pol precursor polyproteins into functional products needed for viral assembly. HIV protease is an aspartic protease encoded by the amino terminus of the pol gene. HIV Proteinase,HTLV-III Protease,p16 pol gene product, HIV,p16 protease, HIV,HIV p16 protease,HTLV III Protease,Protease, HIV,Protease, HTLV-III

Related Publications

J Rittenhouse, and M C Turon, and R J Helfrich, and K S Albrecht, and D Weigl, and R L Simmer, and F Mordini, and J Erickson, and W E Kohlbrenner
September 2012, The FEBS journal,
J Rittenhouse, and M C Turon, and R J Helfrich, and K S Albrecht, and D Weigl, and R L Simmer, and F Mordini, and J Erickson, and W E Kohlbrenner
June 1994, Bio/technology (Nature Publishing Company),
J Rittenhouse, and M C Turon, and R J Helfrich, and K S Albrecht, and D Weigl, and R L Simmer, and F Mordini, and J Erickson, and W E Kohlbrenner
January 1995, Methods in molecular biology (Clifton, N.J.),
J Rittenhouse, and M C Turon, and R J Helfrich, and K S Albrecht, and D Weigl, and R L Simmer, and F Mordini, and J Erickson, and W E Kohlbrenner
January 2000, Methods in molecular biology (Clifton, N.J.),
J Rittenhouse, and M C Turon, and R J Helfrich, and K S Albrecht, and D Weigl, and R L Simmer, and F Mordini, and J Erickson, and W E Kohlbrenner
June 1998, Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology,
J Rittenhouse, and M C Turon, and R J Helfrich, and K S Albrecht, and D Weigl, and R L Simmer, and F Mordini, and J Erickson, and W E Kohlbrenner
June 2003, Biotechnology letters,
J Rittenhouse, and M C Turon, and R J Helfrich, and K S Albrecht, and D Weigl, and R L Simmer, and F Mordini, and J Erickson, and W E Kohlbrenner
March 1991, FEBS letters,
J Rittenhouse, and M C Turon, and R J Helfrich, and K S Albrecht, and D Weigl, and R L Simmer, and F Mordini, and J Erickson, and W E Kohlbrenner
January 2024, Biomimetics (Basel, Switzerland),
J Rittenhouse, and M C Turon, and R J Helfrich, and K S Albrecht, and D Weigl, and R L Simmer, and F Mordini, and J Erickson, and W E Kohlbrenner
April 2021, The protein journal,
J Rittenhouse, and M C Turon, and R J Helfrich, and K S Albrecht, and D Weigl, and R L Simmer, and F Mordini, and J Erickson, and W E Kohlbrenner
June 1996, Immunotechnology : an international journal of immunological engineering,
Copied contents to your clipboard!